<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03789500</url>
  </required_header>
  <id_info>
    <org_study_id>2011-445</org_study_id>
    <nct_id>NCT03789500</nct_id>
  </id_info>
  <brief_title>Influence of Body Size and Composition on Response to Hydromorphone in ED Patients With Acute Pain</brief_title>
  <official_title>Influence of Body Size and Composition on Response to Hydromorphone in ED Patients With Acute Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jacobi Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jacobi Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current study is investigate the association between total body weight, body mass index and
      the clinical response to a fixed dose of intravenous hydromorphone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain numerical rating scale change</measure>
    <time_frame>30 minutes</time_frame>
    <description>pain intensity was measured based on numerical rating scale, 0 -10, with 0 as no pain and 10 as the worst pain intensity</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Pain Conditions</condition>
  <arm_group>
    <arm_group_label>study arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydromorphone</intervention_name>
    <arm_group_label>study arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 65 years of age English or Spanish speaking presenting to the ED with pain of
             less than or equal to 7 days' duration judged by the ED attending physicians to
             require intravenous opioid analgesics

        Exclusion Criteria:

          -  inability or unwillingness to provide informed consent previous allergic reaction to
             hydromorphone systolic blood pressure less than 90 mmHg room air oxygen saturation by
             pulse oximetry &lt; 95% at baseline alcohol or drug intoxication drug seeking behavior as
             judged by the attending physician use of other opioids or benzodiazepines within the
             past 24 hours use of a monoamine oxidase inhibitor in the past 30 days methadone use
             history of COPD, sleep apnea, renal failure, liver disease, or chronic pain syndrome
             (sickle cell disease, peripheral neuropathy, diabetic neuropathy, or fibromyalgia)
             pregnancy or breast feeding and previous enrollment in the same study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 27, 2018</study_first_submitted>
  <study_first_submitted_qc>December 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2018</study_first_posted>
  <last_update_submitted>December 27, 2018</last_update_submitted>
  <last_update_submitted_qc>December 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine</investigator_affiliation>
    <investigator_full_name>Shujun Xia</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

